Publiziert in: Marktpuls, Unternehmen, Neuemissionen
Frei

CREDIT SUISSE NEW ISSUE: 6 American Call Warrants on Novartis Mittwoch, 17. November 2021 - 09:06

Dear Investor

Please find hereafter the details for these new issues:

Ticker

Valor

ISIN

Underlying

Spot

Strike

Ratio

Maturity

Type

Issue price

Impl. Vola

PDF File

ANOVCS 

11 485 0090 

CH 114 850 090 8 

Novartis AG 

CHF 76.50 

CHF 78.00 

15:1 

17.06.2022 

Call 

CHF 0.16 

16.31% 

ANOVCS_114850090_CW_TSi.pdf

BNOVCS 

11 485 0091 

CH 114 850 091 6 

Novartis AG 

CHF 76.50 

CHF 80.00 

15:1 

17.06.2022 

Call 

CHF 0.12 

16.32% 

BNOVCS_114850091_CW_TSi.pdf

CNOVCS 

11 485 0092 

CH 114 850 092 4 

Novartis AG 

CHF 76.50 

CHF 82.00 

15:1 

17.06.2022 

Call 

CHF 0.09 

16.42% 

CNOVCS_114850092_CW_TSi.pdf

DNOVCS 

11 485 0093 

CH 114 850 093 2 

Novartis AG 

CHF 76.50 

CHF 78.00 

15:1 

16.12.2022 

Call 

CHF 0.25 

17.39% 

DNOVCS_114850093_CW_TSi.pdf

ENOVCS 

11 485 0094 

CH 114 850 094 0 

Novartis AG 

CHF 76.50 

CHF 80.00 

15:1 

16.12.2022 

Call 

CHF 0.21 

17.20% 

ENOVCS_114850094_CW_TSi.pdf

FNOVCS 

11 485 0095 

CH 114 850 095 7 

Novartis AG 

CHF 76.50 

CHF 82.00 

15:1 

16.12.2022 

Call 

CHF 0.17 

17.27% 

FNOVCS_114850095_CW_TSi.pdf


Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.

The warrants will be placed directly in the secondary market. Please call 044/335 76 00.

Kind regards

CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08

www.credit-suisse.com

This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.